Changing presentation of seizures with aging: Clinical and etiological factors

Gerontology

Volumn 45, Issue 6, 1999, Pages 329-335

  DeToledo, John C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical presentation; Drug induced; Elderly; Epilepsy; Seizures; Stroke

Indexed keywords

AGING; ARTICLE; CLINICAL FEATURE; DISEASE COURSE; EPILEPTIC AURA; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEIZURE;

AGED; AGING; BRAIN; EPILEPSY; HUMANS; SEIZURES; STATUS EPILEPTICUS;

EID: 0032701751     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022114     Document Type: Article

References (65)

1. Gowers WR: A Manual on Diseases of the Nervous System. Philadelphia, Blackiston & Son, 1888.
2. Hauser WA, Kurland LT: The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975;16:1-66.
3. Hauser WA, Annegers JF, Kurland LT: The prevalence of epilepsy in Rochester, Minnesota, 1940-1980. Epilepsia 1991;32:429-445.
4. Lothman EW: The biochemical basis and pathophysiology of status epilepticus. Neurology 1990;40:13-23.
5. Leppik IE: Metabolism of antiepileptic medication: Newborn to elderly. Epilepsia 1992; 33(suppl 4):S32-S40.
6. Bursztajn HJ, Feinbloom RI, Hamm RM, Brodsky A: Medical Choices, Medical Chances: How Patients, Families and Physicians Can Cope with Uncertainty. New York, Routledge, Chapman & Hall, 1990.
7. DeToledo JC, Haddad H, Smith DB: Pseudotoxicity of antiepileptic drugs in institutionalized patients. Electroencephalogr Clin Neurophysiol 1991;79:59.
8. Haddad H, Icovino J, DeToledo J: Chronic sleep deprivation and daytime naps confused with absence seizures in institutionalized patients. Neurology 1994;44(suppl 2):145.
9. Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1989;30:389-399.
10. DeToledo J: Secondarily Generalized Seizures; in Willmore LJ (ed): Generalized Tonic Clonic Seizures: Identification, Classification and Treatment. Epilepsy. Chicago, CME Monogr, 1995, pp 24-32.
11. DeToledo JC, Ramsay ER: Patterns of involvement of facial muscles during epileptic and nonepileptic events. Neurology 1996;47:621-625.
12. Matson RH, Cramer JA, Collins JF, Smith DB, et al: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized seizures. N Engl J Med 1985;313:145-151.
13. Matson RH, Cramer JA, Collins JF: A comparison of valproate with carbamazepine for the treatment of partial and secondarily generalized tonic clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No 264. N Engl J Med 1992;327:765-771.
14. Henderson G, Tomlinson BE, Gibson PH: Cell counts in human cerebral cortex in normal adults throughout life using an image analyzing computer. J Neurol Sci 1980;46:113-136.
15. Kemper T: Neuroanatomical and neuropathological changes in normal aging and in dementia; in Albert ML (ed): Clinical Neurology of Aging. New York, Oxford University Press, 1984, pp 9-52.
16. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB: Progressive dendritic changes in aging human cortex. Exp Neurol 1975;47:392-403.
17. Gilloteaux J, Linz MH: Histology of aging: Central nervous system. Gerontol Geriatr Educ 1984;4:81-97.
18. Hauser WA: Seizure disorders: The changes with age. Epilepsia 1992;33(suppl 4):S9-S15.
19. Godfrey JBW: Misleading presentation of epilepsy in elderly people. Age Ageing 1989;18: 17-20.
20. DeToledo JC, Haddad H, Smith DB: Behaviors mimicking epilepsy in the mentally ill patients. Electroencephalogr Clin Neurophysiol 1991;79;58.
21. Engel J Jr: Seizures and Epilepsy. Philadelphia, Davis, 1989, p 33.
22. Matsumoto H, Ajmone Marsan C: Cortical cellular phenomena in experimental epilepsy: Interictal manifestations. Exp Neurol 1964;9: 286-304.
23. Prince DA: Inhibition in epileptic neurons. Exp Neurol 1968;21:307-321.
24. Schwartzkroin PA, Prince DA: Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res 1978;147:117-130.
25. Cromwell RM: Distant effects of local epileptogenic process. Brain Res 1980;18:137-154.
26. Collins RC: Use of cortical circuits during focal penicillin seizures: An autoradiographic study with C14 deoxyglucose. Brain Res 1978;150: 487-501.
27. Gutnick MJ, Prince DA: Cortical relay neurons: Antidromic invasion of spikes from the epileptogenic focus. Science 1972;176:424-426.
28. Seino M, Wada JA: Chronic focal cortical epileptogenesis lesion and behavior: Comparison of behavioral performance in monkeys with either epileptogenic or ablative unilateral lesion. Epilepsia 1964;5:321-333.
29. Mori H, Mizutani T, Yoshimura M, Yamanouchi H, Shimada H: Unilateral brain damage after prolonged hemiconvulsions in the elderly associated with theophylline administration. J Neurol Neurosurg Psychiatry 1992;55:466-469.
30. Privitera M, Hoffmann M, Moore JL, Jester D: EEG detection of nontonic clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994;18:155-166.
31. Annegers JF: The epidemiology of epilepsy; in Wyllie E (ed): The Treatment of Epilepsy: Principles and Practices. Philadelphia, Lea & Febiger, 1993, pp 157-164.
32. Lühdorf K, Jensen KL, Plesner AM: Epilepsy in the elderly: Incidence, social function, and disability. Epilepsia 1986;27:135-141.
33. Lesser RP, Lüders H, Dinner DS, Morris HH: Epileptic seizures due to thrombotic and embolic cerebrovascular disease in older patients. Epilepsia 1985;26:622-630.
34. Shinton RA, Gill JS, Zezulka AV, Beevers DG: The frequency of epilepsy preceding stroke: Case-controlled study in 230 patients. Lancet 1987;i:11-12.
35. Faught E, Peters D, Bartolucci A, Moore L, Miller PC: Seizures after primary intracerebral hemorrhage. Neurology 1989;39:1089-1093.
36. Louis S, McDowell F: Epileptic seizures in non-embolic cerebral infarction. Arch Neurol 1967; 17:414-418.
37. Richardson EP, Dodge PR: Epilepsy in cerebral vascular disease. Epilepsia 1954;3:49-65.
38. Olsen TS, Hagenhaven H, Thage O: Epilepsy after stroke. Neurology 1987;37:1209-1211.
39. Cocito L, Favale E, Reni L: Epileptic seizures in cerebral arterial occlusive disease. Stroke 1982;13:189-195.
40. Holmes GL: The EEG as a predictor of seizures following cerebral infarction. Clin EEG 1980; 11:83-86.
41. Meyer JS, Charney JZ, Rivera VM, Mathew NT: Cerebral embolization: Prospective clinical analysis of 42 cases. Stroke 1971;2:541-554.
42. McAreavey MJ, Ballinger BR, Fenton GW: Epileptic seizures in elderly patients with dementia. Epilepsia 1992;33:657-660.
43. Hauser WA, Morris M L, Heston LL, Anderson VE: Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986;36:1226-1230.
44. Romanelli MF, Morris JC, Ashkin K, Koben LA: Advanced Alzheimer's disease is a risk factor for late onset seizures. Arch Neurol 1990; 47:847-850.
45. Annegers JF, Hauser AW, Beghi E, Nicolosi A, Kurland LT: The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407-1410.
46. DeGraff AS: Epidemiological aspects of epilepsy in Northern Norway. Epilepsia 1974;15: 291-299.
47. Bergamini L, Bergamasco B, Benna P, Gilli M: Acquired etiological factors in 1785 epileptic subjects: Clinical anamnestic research. Epilepsia 1977;18:437-444.
48. Nicolosi A, Hauser AW, Beghi E, Kurland LT: The epidemiology of central nervous system infections in Olmstcd County, Minnesota, 1950-1981. J Infect Dis 1986;154:399-408.
49. Foy PM, Copeland GP, Shaw MDM: The incidence of postoperative seizures. Acta Neurochir 1981;55:252-264.
50. Boston Collaborative Drug Surveillance Program: Drug-induced convulsions. Lancet 1972; ii:677-679.
51. Zwillich C, et al: Theophylline induced seizures in adults. Ann Intern Med 1975;82:784-787.
52. Betts TA, Kalra PL, Cooper R, Jeavons PM: Epileptic fits as a probable side effect of amitriptyline. Lancet 1968;i:390-393.
53. Koella WP, Glatt A, Kiebs K, Durst T: Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine and amitriptyline. Biol Psychiatry 1979;14:485-497.
54. Escande M, Gayral L, Goldberger E, Jarrige A, Kulik J: Accidents convulsifs et modifications EEG au cours des traitements par les antidépresseurs tricycliques. Encéphale 1976;II:133-151.
55. Trimble M: New antidepressant drugs and the seizure threshold. Neuropharmacology 1980; 19:1227-1228.
56. Elisson DW, Pentel PR: Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989;7: 5-10.
57. Balant-Gorgia AE, Balant LP, Zysset T: High plasma concentrations of desmethylchlorimipramine after chronic administration of clomipramine to a poor metabolizer. Eur J Clin Pharmacol 1987;32:101-102.
58. Balant-Gorgia AE, Gay M, Gex-Fabry M, Balant LP: Persistent impairment of clomipramine demethylation in recently detoxified alcoholic patients. Ther Drug Monit 1992;14: 119-124.
59. Nielsen KK, Brosen K, Hansen MGJ, Gram LF: Single dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms. Clin Pharmacol Ther 1994;55:518-527.
60. DeToledo JC, Haddad H, Ramsay ER: Status epilepticus associated with the combination of valproic acid and clomipramine. Ther Drug Monit 1997;19:71-73.
61. Lake CR, Gallant S, Masson E, Miller P: Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reports. Am J Med 1990;89:195-208.
62. Hickson GB, Altemeier WA, Clayton EW: Should promethazine in liquid form be available without prescription? Pediatrics 1990;86: 221-225.
63. Fitzgerald JL, Munford HA: Prevalence and extend of drinking in Iowa: 1979. J Stud Alcohol 1981;38:38.
64. DeLorenzo RJ, Towne RA, Pellock JM, Ko D: Status epilepticus in children, adults, and the elderly. Epilepsia 1992;33(suppl 4):S15-S25.
65. Ramsay ER, DeToledo JC: Intravenous administration of fosphenytoin: Options for the management of seizures. Neurology 1996;46 (suppl 1):S17-S19.